Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
Conditions: Colorectal Cancer Interventions: Drug: Tislelizumab with Fruquintinib, Metronidazole Sponsors: Jing-yuan Fang, MD, Ph. D Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | Gastroschisis Repair | Metronidazole | Research